Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma
Authors:
- Gabriele IhorstGIGabriele Ihorst
- David De PasqualeDPDavid De Pasquale
- Percy SchröttnerPSPercy Schröttner
- Alf ZerweckAZAlf Zerweck
- Ralph WäschRWRalph Wäsch
- Monika EngelhardtMEMonika Engelhardt
- 5 November 2010
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 52 (2) , 247-259
Abstract
Multiple myeloma (MM) has been suggested to be associated with different neoplasms. Of 589 consecutive patients with MM, 59 (10%) had different neoplasms: solid tumors in 78% and hematological neoplasms in 22%. Different neoplasms were separated into those emerging prior or synchronously (p/s; n = 41) versus subsequently after the MM (n = 18). The rate of different neoplasms at the time of MM diagnosis was estimated as 6.6%, and estimated different neoplasm rates at 2, 5, and 10 years were 7.8%, 10.3%, and 11.6%, respectively. Patients with MM with p/s different neoplasms showed a hazard ratio (HR) for impaired overall survival of 1.2 (95% CI 0.8-2.0), whereas in those with subsequent neoplasms the HR was 2.5 (95% CI 1.4-4.4). This demonstrates that (1) p/s are more frequent compared with subsequent different neoplasms, and (2) the prognosis is more impaired with subsequent different neoplasms. Age ≥60 years was a confounding covariable with a HR of 2.021 (95% CI 1.6-2.6).Keywords
This publication has 22 references indexed in Scilit:
- Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantationAnnals of Oncology, 2009
- An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimationJournal of Clinical Epidemiology, 2008
- Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working GroupBlood, 2008
- Risk of Subsequent Solid Tumors After Non-Hodgkin's Lymphoma: Effect of Diagnostic Age and Time Since DiagnosisJournal of Clinical Oncology, 2008
- Therapy-related leukemia and myelodysplasia: susceptibility and incidenceHaematologica, 2007
- The risk of secondary malignancies over 30 years after the treatment of non‐Hodgkin lymphomaCancer, 2006
- Familial association of colorectal adenocarcinoma with cancers at other sitesEuropean Journal of Cancer, 2004
- Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958–1996: a search for common mechanismsBritish Journal of Cancer, 2001
- Sustained long-term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapyAmerican Journal of Hematology, 2000
- Second Malignancies in Patients with Multiple MyelomaOncology, 1977